Ronald J. Buckanovich

University of Pittsburgh — United States

Medicine · Health Sciences

54h-index9.8kcitations329works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(71), Cancer Cells and Metastasis(68), Cancer, Hypoxia, and Metabolism(61), Cancer, Lipids, and Metabolism(34), Immunotherapy and Immune Responses(23)

Publications329 total

Figure S3 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
2025Open Access
Figure S5 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
2025Open Access
Figure S2 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
2025Open Access
Figure S1 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
2025Open Access
Figure S4 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
2025Open Access
Table S1 from Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
2025Open Access
EGFL6 is a novel HER3 ligand, inducing HER3/integrin heterodimers to induce pERK centrosomal deposition and therapeutic resistance
Neoplasia·2025Open Access
Abstract B054: TGFBI modulates immune cell infiltration in ovarian cancer and represents a potential therapeutic target
Cancer Research·2025
The Paraneoplastic Antigen Nova-1 is a Neuron Specific and Sequence Specific RNA Binding Protein
Digital Commons - RU (Rockefeller University)·2025Open Access
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
2025Open Access
Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer
Disease Models & Mechanisms·2025Open Access
Supplementary Table 2 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
Supplementary Figure 7 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
Supplementary Figure 4 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
Data from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025· 1 citedOpen Access
Supplementary Figure 6 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
Supplementary Figure 5 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
Supplementary Figure 2 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
Supplementary Table 1 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
Supplementary Figure 1 from Aged and <i>BRCA</i>-Mutated Stromal Cells Drive Epithelial Cell Transformation
2025Open Access
page 1 of 17Next →

Frequent Co-authors

George Coukos(11), Lan Coffman(11), Karen McLean(9), Fabián Benencia(8), José R. Conejo-García(8), Shoumei Bai(6), Kun Yang(6), Geeta Mehta(6), Marı́a C. Courrèges(5), Euisik Yoon(5), R. Kevin Reynolds(4), Robert B. Darnell(4), Daniela Burgos-Ojeda(4), Phyllis A. Gimotty(3), Dionyssios Katsaros(3), Kathleen R. Cho(3), Chelsea Chandler(3), Pooja Mehta(3), Yu‐Chih Chen(3), Patrick Ingram(3)